Physician profile
Eric J Lescault
NPI 1992772248
$2,812.34
in general payments reported to CMS, 2019-2025
10 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $134 · 2021: $161 · 2022: $1,484 · 2023: $421 · 2024: $189 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,116.27 | 2020-2025 | Mako, Tornier Perform Reversed Glenoid, Aequalis Perform Reversed |
| Zimmer Biomet Holdings, INC. | $188.45 | 2021-2022 | |
| Smith+Nephew, INC. | $181.73 | 2019-2025 | Stravix |
| Anika Therapeutics, INC. | $115.60 | 2022 | |
| Horizon Therapeutics Plc | $64.94 | 2019 | |
| Microport Orthopedics INC | $59.41 | 2020 | |
| Orthofix Medical, INC. | $36.57 | 2019-2020 | |
| Linvatec Corporation | $21.14 | 2023 | Biobrace 23mm, Linvatec 2dhd Video Systems, Allograft Tissue |
| Radius Health, INC. | $16.17 | 2019 | |
| Pacira Therapeutics, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lescault listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.